Skip to main content
SpringerLink
Log in

Experiments and modeling of controlled release behavior of commercial and model polymer-drug formulations using dialysis membrane method

  • Original Article
  • Published:
Drug Delivery and Translational Research Aims and scope Submit manuscript

Abstract

Standard dissolution testing methods typically do not correlate strongly with the in vivo drug release behavior for the oral delivery products, since they only focus on the drug dissolution in the gastric/intestinal fluid and do not account for the intestinal absorption of drug. Artificial gastrointestinal systems attempt to bridge this gap by using dialysis membranes as a proxy for the intestinal membranes. We present a systematic proof-of-concept study of how the drug dissolution and drug absorption are mimicked in such systems for the case of polymer-drug formulations. We utilize a modified version of the conventional shaking-flask test, in which the drug formulation is placed inside a dialysis bag. Dissolution experiments are performed on a commercial aspirin formulation and model formulations of aspirin with varying amounts of poly-methyl-methacrylate-co-methacrylic acid (PMA-MAA), both for conventional and modified shaking-flask test. Results are successfully interpreted using a simple model that assumes first-order kinetics for both the drug release from the formulation and drug permeation through the membrane. The differences between the model and commercial formulations and the effects of shaking speed and drug loading are established by comparison of the first-order rate constants. Finally, comparison with a reported in vivo study demonstrates how the modified shaking-flask setup can be used to improve the in vitro in vivo correlation.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Kost J, Langer R. Responsive polymeric delivery systems. Adv Drug Deliv Rev. 2012;64:327–41. https://doi.org/10.1016/j.addr.2012.09.014.

    Article  Google Scholar 

  2. Liechty WB, Kryscio DR, Slaughter BV, Peppas NA. Polymers for drug delivery systems. Annu Rev Chem Biomol 2010;1:149–73. https://doi.org/10.1146/annurev-chembioeng-073009-100847.Polymers.

    Article  CAS  Google Scholar 

  3. Uhrich KE, Cannizzaro SM, Langer RS, Shakesheff KM. Polymeric systems for controlled drug release. Chem Rev. 1999;99:3181–98. https://doi.org/10.1021/cr940351u.

    Article  CAS  PubMed  Google Scholar 

  4. Schmaljohann D. Thermo- and PH-responsive polymers in drug delivery. Adv Drug Deliv Rev. 2006;58(15):1655–70. https://doi.org/10.1016/j.addr.2006.09.020.

    Article  CAS  PubMed  Google Scholar 

  5. Marques MRC; Loebenberg R; Almukainzi M Simulated biologic fluids with possible application in dissolution testing. Dissolution Technol. 2011, No. August, 15–28. https://doi.org/10.1002/jps.23029.

  6. Abouelmagd SA, Sun B, Chang AC, Ku YJ, Yeo Y. Release kinetics study of poorly water-soluble drugs from nanoparticles: are we doing it right? Mol Pharmaceut 2015;12(3):997–1003. https://doi.org/10.1021/mp500817h.

    Article  CAS  Google Scholar 

  7. Scholz A, Kostewicz E, Abrahamsson B, Dressman JB. Can the USP paddle method be used to represent in-vivo hydrodynamics? J Pharm Pharmacol. 2003;55(4):443–51. https://doi.org/10.1211/002235702946.

    Article  PubMed  Google Scholar 

  8. Amidon GL; Sinko PJ; Fleisher D Estimating human oral fraction dose absorbed: a correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds. Pharm Res 1988, pp 651–654. https://doi.org/10.1023/A:1015927004752.

  9. Yu LX, Lipka E, Crison JR, Amidon GL. Transport approaches to the biopharmaceutical design of oral-drug delivery systems - prediction of intestinal-absorption. Adv Drug Deliv Rev. 1996;19:359–76.

    Article  CAS  Google Scholar 

  10. Hens B, Corsetti M, Spiller R, Marciani L, Vanuytsel T, Tack J, et al. Exploring gastrointestinal variables affecting drug and formulation behavior: methodologies, challenges and opportunities. Int J Pharm. 2017;519(1–2):79–97. https://doi.org/10.1016/j.ijpharm.2016.11.063.

    Article  CAS  PubMed  Google Scholar 

  11. Shargel L; Wu-Pong S; Yu ABC Applied Biopharmaceutics & Pharmacokinetics; Appleton & Lange Reviews/McGraw-Hill, Medical Pub. Division, 2005.

  12. Yu LX, Crison JR, Amidon GL. Compartmental transit and dispersion model analysis of small intestinal transit flow in humans. Int J Pharm. 1996;140(1):111–8. https://doi.org/10.1016/0378-5173(96)04592-9.

    Article  CAS  Google Scholar 

  13. Willmann S, Schmitt W, Keldenich J, Dressman JB. A physiologic model for simulating gastrointestinal flow and drug absorption in rats. Pharm Res. 2003;20(11):1766–71. https://doi.org/10.1023/B:PHAM.0000003373.72652.c0.

    Article  CAS  PubMed  Google Scholar 

  14. Abbiati RA, Lamberti G, Grassi M, Trotta F, Manca D. Definition and validation of a patient-individualized physiologically-based pharmacokinetic model. Comput Chem Eng. 2016;84:394–408. https://doi.org/10.1016/j.compchemeng.2015.09.018.

    Article  CAS  Google Scholar 

  15. Cascone S, Lamberti G, Piazza O, Abbiati RA, Manca D. A physiologically-based model to predict individual pharmacokinetics and pharmacodynamics of remifentanil. Eur J Pharm Sci. 2018;111:20–8. https://doi.org/10.1016/j.ejps.2017.09.028.

    Article  CAS  PubMed  Google Scholar 

  16. Grassi M, Lamberti G, Cascone S, Grassi G. Mathematical modeling of simultaneous drug release and in vivo absorption. Int J Pharm. 2011;418(1):130–41. https://doi.org/10.1016/j.ijpharm.2010.12.044.

    Article  CAS  PubMed  Google Scholar 

  17. Ferrua MJ, Singh RP. Modeling the fluid dynamics in a human stomach to gain insight of food digestion. J Food Sci. 2010;75(7):151–62. https://doi.org/10.1111/j.1750-3841.2010.01748.x.

    Article  CAS  Google Scholar 

  18. Levy G, Leonards JR, Procknal JA. Development of in vitro dissolution tests which correlate quantitatively with dissolution rate-limited drug absorption in man. J Pharm Sci. 1965;54(12):1719–22. https://doi.org/10.1002/jps.2600541204.

    Article  CAS  Google Scholar 

  19. Blanquet S, Zeijdner E, Beyssac E, Meunier JP, Denis S, Havenaar R, et al. A dynamic arificial gastrointestinal system for studying the behavior of orally administrated drug dosage forms under various physiological conditions. Pharm Res. 2004;21(4):585–91. https://doi.org/10.1023/B:PHAM.0000022404.70478.4b.

    Article  CAS  PubMed  Google Scholar 

  20. Todaro V, Persoons T, Grove G, Healy AM, D’Arcy DM. Characterization and simulation of hydrodynamics in the paddle, basket and flow-through dissolution testing apparatuses-a review. Dissolut Technol 2017;24(3):24–36. https://doi.org/10.14227/DT240317P24.

    Article  Google Scholar 

  21. Lu Z, Fassihi R. Mechanistic approach to understanding the influence of USP apparatus I and II on dissolution kinetics of tablets with different operating release mechanisms. AAPS PharmSciTech. 2017;18(2):462–72. https://doi.org/10.1208/s12249-016-0535-x.

    Article  CAS  PubMed  Google Scholar 

  22. Arroyo E, Luque PA, Cosio M, Soto C, Villarreal R, Nava O, et al. Study of a controlled release polymeric system based on pluronic P123: spectroscopic characterization and theoretical model approach. J Mol Struct. 2017;1138:172–6. https://doi.org/10.1016/J.MOLSTRUC.2017.03.018.

    Article  CAS  Google Scholar 

  23. Trasi NS, Purohit HS, Wen H, Sun DD, Taylor LS. Non-sink dissolution behavior and solubility limit of commercial tacrolimus amorphous formulations. J Pharm Sci. 2017;106(1):264–72. https://doi.org/10.1016/J.XPHS.2016.09.016.

    Article  CAS  PubMed  Google Scholar 

  24. Yoshida T, Lai TC, Kwon GS, Sako K. PH- and ion-sensitive polymers for drug delivery. Expert Opin Drug Del 2013;10(11):1497–513. https://doi.org/10.1517/17425247.2013.821978.

    Article  CAS  Google Scholar 

  25. Higuchi BT, Elowe LN. The physics of tablet compression. J Am Pharm Assoc. 1954;43(11):685–9. https://doi.org/10.1002/jps.3030431118.

    Article  CAS  Google Scholar 

  26. Katori N, Aoyagi N, Terao T. Estimation of agitation intensity in the GI tract in humans and dogs based on in vitro/in vivo correlation. Pharm Res. 1995;12(2):237–43. https://doi.org/10.1023/A:1016231010301.

    Article  CAS  PubMed  Google Scholar 

  27. Siepmann J, Peppas NA. Higuchi equation: derivation, applications, use and misuse. Int J Pharm 2011;418(1):6–12. https://doi.org/10.1016/j.ijpharm.2011.03.051.

    Article  CAS  PubMed  Google Scholar 

  28. Siepmann J, Siepmann F. Mathematical modeling of drug delivery. Int J Pharm. 2008;364(2):328–43. https://doi.org/10.1016/j.ijpharm.2008.09.004.

    Article  CAS  PubMed  Google Scholar 

  29. Souliman S, Beyssac E, Cardot JM, Denis S, Alric M. Investigation of the biopharmaceutical behavior of theophylline hydrophilic matrix tablets using USP methods and an artificial digestive system. Drug Dev Ind Pharm. 2007;33(4):475–83. https://doi.org/10.1080/03639040601128654.

    Article  CAS  PubMed  Google Scholar 

  30. Blanquet S, Zeijdner E, Beyssac E, Meunier J, Denis S, Havenaar R, et al. A Dynamic artificial gastrointestinal system for studying the behavior of orally administered drug dosage forms under various physiological conditions. Pharm Res. 2004;21(4):585–91.

    Article  CAS  Google Scholar 

  31. Minekusr M, Marteaul P, Havenaarl R, Huis JHJ. A multicompartmental dynamic computer- controlled model simulating the stomach and small intestine. ATLA. 1995;23(January 1995):197–209.

    Google Scholar 

  32. Alam MA, Al-Jenoobi FI, Al-Mohizea AM. Everted Gut Sac Model as a tool in pharmaceutical research: limitations and applications. J Pharm Pharmacol. 2012;64(3):326–36. https://doi.org/10.1111/j.2042-7158.2011.01391.x.

    Article  CAS  PubMed  Google Scholar 

  33. Ruan LP, Chen S, Yu BY, Zhu DN, Cordell GA, Qiu SX. Prediction of human absorption of natural compounds by the non-everted rat intestinal sac model. Eur J Med Chem. 2006;41(5):605–10. https://doi.org/10.1016/j.ejmech.2006.01.013.

    Article  CAS  PubMed  Google Scholar 

  34. Rosen A, Macheras P. Effect of protein on the absorption of phenytoin through everted gut preparations. J Pharm Pharmacol. 1985;37(3):154–8. https://doi.org/10.1111/j.2042-7158.1985.tb05031.x.

    Article  CAS  PubMed  Google Scholar 

  35. Xie L, Beyer S, Vogel V, Wacker MG, Mäntele W. Assessing the drug release from nanoparticles: overcoming the shortcomings of dialysis by using novel optical techniques and a mathematical model. Int J Pharm. 2015;488(1–2):108–19. https://doi.org/10.1016/j.ijpharm.2015.03.080.

    Article  CAS  PubMed  Google Scholar 

  36. Kopelman R. Fractal reaction kinetics. Science (80- ). 1988;241(4873):1620–6. https://doi.org/10.1126/science.241.4873.1620.

    Article  CAS  Google Scholar 

  37. Macheras P; Iliadis A Modeling in biopharmaceutics, pharmacokinetics and pharmacodynamics; Interdisciplinary Applied Mathematics; Springer International Publishing: Cham, 2016; Vol. 30. https://doi.org/10.1007/978-3-319-27598-7.

  38. Macheras, P.; Argyrakis, P. Gastrointestinal drug absorption: is it time to consider heterogeneity as well as homogeneity? Pharm Res. Kluwer Academic Publishers-Plenum Publishers 1997, pp 842–847. https://doi.org/10.1023/A:1012183313218.

  39. Hoa NT, Kinget R. Design and evaluation of two-phase partition-dissolution method and its use in evaluating artemisinin tablets. J Pharm Sci. 1996;85(10):1060–3. https://doi.org/10.1021/js960115u.

    Article  CAS  PubMed  Google Scholar 

  40. Charman WN, Charman SA, Monkhouse DC, Frisbee SE, Lockhart EA, Weisman S, et al. Biopharmaceutical characterisation of a low-dose (75 Mg) controlled-release aspirin formulation. Br J Clin Pharmacol. 1993;36(5):470–3. https://doi.org/10.1111/j.1365-2125.1993.tb00399.x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Manga RD, Jha PK. Mathematical models for controlled drug release through PH-responsive polymeric hydrogels. J Pharm Sci. 2017;106(2):629–38. https://doi.org/10.1016/j.xphs.2016.10.019.

    Article  CAS  PubMed  Google Scholar 

  42. Gupta PK, Hung CT, Perrier DG. Quantitation of the release of doxorubicin from colloidal dosage forms using dynamic dialysis. J Pharm Sci. 1987;76(2):141–5.

    Article  CAS  Google Scholar 

  43. Schmuckler JS. Buffer Solutions. J Chem Educ. 1982;59(4):305. https://doi.org/10.1021/ed059p305.4.

    Article  Google Scholar 

  44. Khan F, Li M, Schlindwein W. Comparison of in vitro dissolution tests for commercially available aspirin tablets. Dissolution Technol. 2013;20(1):48–58. https://doi.org/10.14227/DT200113P48.

    Article  CAS  Google Scholar 

  45. Torrado S, Cadorniga R, Torrado JJ. Effect of drug release rate on bioavailability of different aspirin tablets. Int J Pharm 1996;133(1–2):65–70. https://doi.org/10.1016/0378-5173(95)04411-6.

    Article  CAS  Google Scholar 

  46. Bunde A, Havlin S, Nossal R, Stanley HE, Weiss GH. On controlled diffusion-limited drug release from a leaky matrix. J Chem Phys. 1985;83(11):5909–13. https://doi.org/10.1063/1.449622.

    Article  CAS  Google Scholar 

  47. Kosmidis K, Argyrakis P, Macheras P. Fractal kinetics in drug release from finite fractal matrices. J Chem Phys. 2003;119(12):6373–7. https://doi.org/10.1063/1.1603731.

    Article  CAS  Google Scholar 

  48. Singh K, Satapathi S, Jha PK. “Ant-Wall” model to study drug release from excipient matrix. Phys A Stat Mech its Appl. 2019;519:98–108. https://doi.org/10.1016/J.PHYSA.2018.12.029.

    Article  CAS  Google Scholar 

  49. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 1983;15(1):25–35. https://doi.org/10.1016/0378-5173(83)90064-9.

    Article  CAS  Google Scholar 

  50. Ensign LM, Cone R, Hanes J. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv Drug Deliv Rev. 2012;64(6):557–70. https://doi.org/10.1016/j.addr.2011.12.009.

    Article  CAS  PubMed  Google Scholar 

  51. Membrez M, Blancher F, Jaquet M, Bibiloni R, Cani PD, Burcelin RG, et al. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J. 2008;22(7):2416–26. https://doi.org/10.1096/fj.07-102723.

    Article  CAS  PubMed  Google Scholar 

  52. Pedersen BT, Østergaard J, Larsen SW, Larsen C. Characterization of the rotating dialysis cell as an in vitro model potentially useful for simulation of the pharmacokinetic fate of intra-articularly administered drugs. Eur J Pharm Sci. 2005;25(1):73–9. https://doi.org/10.1016/j.ejps.2005.01.019.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank Raminder Kaur Sekhon and Yash Pal Gangwar for some preliminary work related to this paper.

Funding sources

This work is supported by a research grant from the Science and Engineering Research Board (SERB), India (no. YSS/2015/001228).

Author information

Authors and Affiliations

  1. Department of Chemical Engineering, Indian Institute of Technology Roorkee, Roorkee, Uttarakhand, 247667, India

    Alok Ranjan & Prateek K. Jha

Authors
  1. Alok Ranjan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prateek K. Jha
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Prateek K. Jha.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ranjan, A., Jha, P.K. Experiments and modeling of controlled release behavior of commercial and model polymer-drug formulations using dialysis membrane method. Drug Deliv. and Transl. Res. 10, 515–528 (2020). https://doi.org/10.1007/s13346-019-00696-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13346-019-00696-1

Keywords

Search

Navigation